Humacyte, Inc.
HUMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $19 | $38 | $63 | $45 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $18 | $11 | $8 | $0 |
| Other Curr. Assets | $2 | $2 | $2 | $3 |
| Total Curr. Assets | $41 | $52 | $74 | $48 |
| Property Plant & Equip (Net) | $49 | $36 | $37 | $39 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $51 | $51 | $51 |
| Total NC Assets | $50 | $87 | $89 | $90 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $92 | $139 | $163 | $138 |
| Liabilities | – | – | – | – |
| Payables | $10 | $7 | $6 | $4 |
| Short-Term Debt | $3 | $5 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $9 | $11 | $13 |
| Total Curr. Liab. | $26 | $21 | $20 | $20 |
| LT Debt | $27 | $79 | $13 | $14 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $44 | $35 | $94 | $157 |
| Total NC Liab. | $71 | $114 | $106 | $171 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $15 | $16 | $17 |
| Total Liabilities | $96 | $135 | $127 | $191 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $0 | $0 | $0 |
| Retained Earnings | -$702 | -$685 | -$647 | -$686 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $694 | $689 | $683 | $633 |
| Total Equity | -$5 | $4 | $36 | -$53 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $92 | $139 | $163 | $138 |
| Net Debt | $10 | $46 | -$47 | -$28 |